US Stock MarketDetailed Quotes
CANF Can-Fite BioPharma
- 1.9800
- +0.0600+3.13%
Close Apr 26 16:00 ET
- 1.8300
- -0.1500-7.58%
Post 17:37 ET
9.88MMarket Cap-660P/E (TTM)
2.0100High1.9100Low8.67KVolume2.0000Open1.9200Pre Close16.94KTurnover0.17%Turnover RatioLossP/E (Static)4.99MShares3.330052wk High1.58P/B9.88MFloat Cap1.705152wk Low--Dividend TTM4.99MShs Float1419.0000Historical High--Div YieldTTM5.21%Amplitude1.5200Historical Low1.9550Avg Price1Lot Size
About Can-Fite BioPharma Company
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
Company Profile
SymbolCANF
Company NameCan-Fite BioPharma
Listing DateSep 10, 2012
Founded1994
CEOMr. Motti Farbstein
MarketAMEX
Employees5
Securities TypeDR
ADS Ratio1.0 : 300.0
Fiscal Year Ends12-31
Address26 Ben Gurion Street
CityRamat Gan
CountryIsrael
Zip Code5257346
Phone972-3-924-1114
Websitehttp://www.canfite.com
Company Executives
- Name
- Position
- Salary
- Motti Farbstein
- Chief Executive Officer, Chief Operating and Financial Officer
- 467.00K
- Dr. Pnina Fishman, PhD
- Chief Scientific Officer and Executive Chairman of the Board
- 703.00K
- Dr. Sari Fishman, PhD
- Vice President, Business Development
- 373.00K
- Dr. Abraham Sartani
- Director
- --
- Dr. Ilan Cohn, PhD
- Director
- --
- Yoseph Bornstein
- Independent Director
- --
- Yaacov Goldman
- Independent Director
- 60.00K
- Guy Regev
- Independent Director
- 60.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg